Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: The strong heart study

Diabetes Care

Volumn 26, Issue 1, 2003, Pages 16-23

  Lu, Weiquan ^b   Resnick, Helaine E ^b   Jablonski, Kathleen A ^b   Jones, Kristina L ^b   Jain, Arvind K ^b   Howard, W M James ^b   Robbins, David C ^b   Howard, Barbara V ^a  

^a MEDSTAR RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GEOGRAPHY; HUMAN; INTERVIEW; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TRIGLYCERIDES;

EID: 0037479469     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.1.16     Document Type: Article

References (47)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
2. Pyorala K, Laakso M, Uustitupa M: Diabetes and atherosclerosis: an epidemiology view. Diabetes Metab Rev 3:463-524, 1987
3. Department of Health and Human Services: Indian Health Service: HIS chart series book. Washington, DC, U.S. Govt. Printing Office, 1984
4. Sievers ML, Nelson RG, Knowler WC, Bennett PH: Impact of NIDDM on mortality and causes of death in Pima Indians. Diabetes Care 15:1541-1549, 1992
5. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, Howard WJ, Rhoades ER, Robbins DC, Sievers ML, Welty TK: The rising tide of cardiovascular disease in American Indians: the Strong Heart Study. Circulation 99:2389-2395, 1999
6. Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK: Coronary heart disease prevalence and its relation to risk factors in American Indians: the Strong Heart Study. Am J Epidemiol 142:254-268, 1995
7. Howard BV: Risk factors for cardiovascular disease in individuals with diabetes: the Strong Heart Study. Acta Diabetol 33:180-184, 1996
8. Howard BV, Lee ET, Fabsitz RR, Robbins DC, Yeh JL, Cowan LD, Welty TK: Diabetes and coronary heart disease in American Indians: the Strong heart Study. Diabetes 45:S6-S13, 1996
9. Howard BV, Robbins DC, Cowan LD, Lee ET, Go OT, Welty TK: Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diabetes Care 21:1258-1265, 1998
10. Reaven GM: Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism 36 (Suppl. 1):1-8, 1987
11. Barrett-Connor E, Grundy SM: Holdbrook JJ: Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 115:657-663, 1982
12. Wilson PW, Kannel WB, Anderson KM: Lipids glucose tolerance and vascular disease: the Framingham Study. Monogr Atheroscler 13:1-11, 1985
13. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 256:2835-2838, 1986
14. Pedersen TR, Olsson AG, Feargeman O, Kjekshus J, Wedel H, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyorala K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ: Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 97:1453-1460, 1998
15. Barbagallo CM, Averna MR, Amato S, Marino G, Labisi M, Rao AC, Barbagallo M, Cupidi GF, Notarbartolo A: Apolipoprotein profile in type II diabetic patients with and without coronary heart disease. Acta Diabetol Latina 27:371-377, 1990
16. Havel RJ, Rapaport E: Management of primary hyperlipidemia. N Engl J Med 332:1491-1498, 1995
17. Frost PH, Havel RJ: Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol 81:26B-31B, 1998
18. Garg A, Grundy SM: Management of dyslipidemia in NIDDM. Diabetes Care 13:153-169, 1990
19. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161:1413-1419, 2001
20. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
21. Lee ET, Welty TK, Fabsitz RR, Cowan LD, Le NA, Oopik AJ, Cucchiara AJ, Savage PJ, Howard BV: The Strong Heart Study: a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 132:1141-1155, 1990
22. Howard BV, Welty TK, Fabsitz RR, Cowan LD, Oopik AJ, Le NA, Yeh JL, Savage PJ, Lee ET: Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans: the Strong Heart Study. Diabetes 41 (Suppl. 2):4-11, 1992
23. Stoddart M, Jarvis B, Blake B, Fabsitz RR, Welty TK, Lee ET, Howard BV: Recruitment of American Indians in epidemiologic research: the Strong Heart Study. J Natl Center Am Indian Alaska Native Ment Health Res 9:20-37, 2000
24. Robbins DC, Welty TK, Wang WY, Lee ET, Howard BV: Plasma lipids and lipoprotein concentrations among American Indians: comparison with U.S. population. Curr Opin Lipidol 7:188-196, 1996
25. Department of Health, Education, and Welfare: Lipid Research Clinics Program: manual of laboratory operations. Vol. 1. Washington, DC, U.S. Govt. Printing Office, 1994 (DHEW publ. no. 75-628)
26. von Clauss A: Gerinnungsphysiologische scnellmethods zur bestimmung des fibrinogens. Acta Haematol 17:237-246, 1957
27. Little RR, England JD, Wiedmeyer HM: Interlaboratory standardization of glycated hemoglobin determinations. Clin Chem 32:358-360, 1986
28. Vasquez B, Flock EV, Savage PJ, Nagulesparan M, Bennion LJ, Baird HR, Bennett PH: Sustained reduction of proteinuria in type 2 (non-insulin dependent) diabetes following diet-induced reduction of hyperglycemia. Diabetologia 26:127-133, 1984
29. Chasson AL, Grady HJ, Stanley MA: Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol 30:207-212, 1960
30. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
31. Department of Health and Human Services: Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Washington, DC, U.S. Govt. Printing Office, 1993 (NIH publ. no. 93-1088)
32. Alberti KGMM, Zimmet PZ, for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
33. Lee ET, Cowan LD, Howard WJ, Sievers M, Welty TK, Wang W, Yeh JL, Rhoades ER, Devereux RB, Fabsitz RR, Go O, Howard BV: All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-75 years, 1984-1988: the Strong Heart Study. Am J Epidemiol 147:995-1008, 1998
34. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
35. Expert Panel (Adult Treatment Panel II): Detection, evaluation, and treatment of high blood cholesterol in adults. Circulation 89:1329-1445, 1994
36. Winkleby MA, Robinson TN, Sundquist J, Kraemer HC: Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 281:1006-1013, 1999
37. Winkleby MA, Kraemer HC, Ahn DK, Varady AN: Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 280:356-362, 1998
38. Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M: Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 46:1354-1359, 1997
39. Gardner CD, Fortmann SP, Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276:875-881, 1996
40. Haffner SM: Management of dyslipidemia in adults with diabetes. Diabetes Care 21:160-178, 1998
41. Gardner CD, Winkleby MA, Fortmann SP: Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). Am J Cardiol 86:299-304, 2000
42. Niskanen L, Turpeinen A, Penttila I, Uusitupa MI. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes Care 21:1861-1869, 1998
43. Austin MA: Plasma triglyceride as a risk factor for cardiovascular disease. Can J Cardiol 14 (Suppl. B):14B-17B, 1998
44. Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Disc Risk 3:213-219, 1996
45. Kannel WB: The Framingham Study: its 50-year legacy and future promise. J Atheroscler Thromb 6:60-66, 2000
46. Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP Jr, Isaacsohn JL, Wassertheil-Smoller S, Wilson AC, Stamler J: Serum lipids and incidence of coronary heart disease: findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation 94:2381-2388, 1996
47. Menotti A, Lanti M, Puddu PE, Mancini M, Zanchetti A, Cirillo M, Vagnarelli OT: First risk functions for prediction of coronary and cardiovascular disease incidence in the Gubbio Population Study. Italian Heart J 1:394-399, 2000